Geron Discontinues Phase 3 Myelofibrosis Trial
Geron announced a decision to discontinue the Phase 3 IMpactMF trial evaluating imetelstat in relapsed/refractory myelofibrosis.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.